nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP3A4—Thiotepa—sarcoma	0.182	0.404	CbGbCtD
Ranolazine—CYP3A4—Mitoxantrone—sarcoma	0.0783	0.174	CbGbCtD
Ranolazine—CYP3A4—Vincristine—sarcoma	0.0539	0.12	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—sarcoma	0.053	0.118	CbGbCtD
Ranolazine—CYP3A4—Etoposide—sarcoma	0.0494	0.11	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—sarcoma	0.0337	0.0748	CbGbCtD
Ranolazine—Carvedilol—VEGFA—sarcoma	0.00338	1	CrCbGaD
Ranolazine—Somnolence—Thiotepa—sarcoma	0.00159	0.00291	CcSEcCtD
Ranolazine—Renal failure acute—Epirubicin—sarcoma	0.00159	0.0029	CcSEcCtD
Ranolazine—Dyspepsia—Thiotepa—sarcoma	0.00157	0.00288	CcSEcCtD
Ranolazine—Hot flush—Epirubicin—sarcoma	0.00157	0.00287	CcSEcCtD
Ranolazine—Confusional state—Mitoxantrone—sarcoma	0.00156	0.00285	CcSEcCtD
Ranolazine—Nervous system disorder—Vincristine—sarcoma	0.00155	0.00285	CcSEcCtD
Ranolazine—Decreased appetite—Thiotepa—sarcoma	0.00155	0.00285	CcSEcCtD
Ranolazine—Menopausal symptoms—Epirubicin—sarcoma	0.00155	0.00284	CcSEcCtD
Ranolazine—Thrombocytopenia—Vincristine—sarcoma	0.00155	0.00284	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00154	0.00283	CcSEcCtD
Ranolazine—Decreased appetite—Dactinomycin—sarcoma	0.00154	0.00282	CcSEcCtD
Ranolazine—Fatigue—Thiotepa—sarcoma	0.00154	0.00282	CcSEcCtD
Ranolazine—Hyperhidrosis—Vincristine—sarcoma	0.00153	0.00281	CcSEcCtD
Ranolazine—Fatigue—Dactinomycin—sarcoma	0.00153	0.0028	CcSEcCtD
Ranolazine—Constipation—Thiotepa—sarcoma	0.00153	0.0028	CcSEcCtD
Ranolazine—Shock—Mitoxantrone—sarcoma	0.00152	0.00278	CcSEcCtD
Ranolazine—Muscle spasms—Etoposide—sarcoma	0.00151	0.00277	CcSEcCtD
Ranolazine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00151	0.00277	CcSEcCtD
Ranolazine—Anorexia—Vincristine—sarcoma	0.00151	0.00277	CcSEcCtD
Ranolazine—Skin disorder—Mitoxantrone—sarcoma	0.0015	0.00275	CcSEcCtD
Ranolazine—Lethargy—Epirubicin—sarcoma	0.00149	0.00274	CcSEcCtD
Ranolazine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00149	0.00273	CcSEcCtD
Ranolazine—Hypotension—Vincristine—sarcoma	0.00148	0.00271	CcSEcCtD
Ranolazine—Feeling abnormal—Thiotepa—sarcoma	0.00147	0.0027	CcSEcCtD
Ranolazine—Anorexia—Mitoxantrone—sarcoma	0.00147	0.00269	CcSEcCtD
Ranolazine—Renal failure acute—Doxorubicin—sarcoma	0.00147	0.00269	CcSEcCtD
Ranolazine—Pain in extremity—Epirubicin—sarcoma	0.00146	0.00268	CcSEcCtD
Ranolazine—Diplopia—Epirubicin—sarcoma	0.00146	0.00268	CcSEcCtD
Ranolazine—Feeling abnormal—Dactinomycin—sarcoma	0.00146	0.00268	CcSEcCtD
Ranolazine—Gastrointestinal pain—Thiotepa—sarcoma	0.00146	0.00268	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00145	0.00266	CcSEcCtD
Ranolazine—Hot flush—Doxorubicin—sarcoma	0.00145	0.00265	CcSEcCtD
Ranolazine—Hypotension—Mitoxantrone—sarcoma	0.00144	0.00264	CcSEcCtD
Ranolazine—Menopausal symptoms—Doxorubicin—sarcoma	0.00144	0.00263	CcSEcCtD
Ranolazine—Insomnia—Vincristine—sarcoma	0.00143	0.00263	CcSEcCtD
Ranolazine—Paraesthesia—Vincristine—sarcoma	0.00142	0.00261	CcSEcCtD
Ranolazine—Urticaria—Thiotepa—sarcoma	0.00142	0.0026	CcSEcCtD
Ranolazine—Vertigo—Etoposide—sarcoma	0.00141	0.00259	CcSEcCtD
Ranolazine—Abdominal pain—Thiotepa—sarcoma	0.00141	0.00259	CcSEcCtD
Ranolazine—Leukopenia—Etoposide—sarcoma	0.00141	0.00258	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—sarcoma	0.0014	0.00257	CcSEcCtD
Ranolazine—Paraesthesia—Mitoxantrone—sarcoma	0.00139	0.00254	CcSEcCtD
Ranolazine—Loss of consciousness—Etoposide—sarcoma	0.00138	0.00253	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—sarcoma	0.00138	0.00253	CcSEcCtD
Ranolazine—Decreased appetite—Vincristine—sarcoma	0.00138	0.00252	CcSEcCtD
Ranolazine—Dyspnoea—Mitoxantrone—sarcoma	0.00138	0.00252	CcSEcCtD
Ranolazine—Cough—Etoposide—sarcoma	0.00137	0.00251	CcSEcCtD
Ranolazine—Somnolence—Mitoxantrone—sarcoma	0.00137	0.00251	CcSEcCtD
Ranolazine—Blood creatinine increased—Epirubicin—sarcoma	0.00137	0.00251	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Vincristine—sarcoma	0.00137	0.00251	CcSEcCtD
Ranolazine—Fatigue—Vincristine—sarcoma	0.00137	0.0025	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—sarcoma	0.00136	0.00249	CcSEcCtD
Ranolazine—Dyspepsia—Mitoxantrone—sarcoma	0.00136	0.00249	CcSEcCtD
Ranolazine—Constipation—Vincristine—sarcoma	0.00136	0.00248	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—sarcoma	0.00135	0.00248	CcSEcCtD
Ranolazine—Pain in extremity—Doxorubicin—sarcoma	0.00135	0.00248	CcSEcCtD
Ranolazine—Decreased appetite—Mitoxantrone—sarcoma	0.00134	0.00246	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—sarcoma	0.00134	0.00245	CcSEcCtD
Ranolazine—Fatigue—Mitoxantrone—sarcoma	0.00133	0.00244	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00133	0.00244	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—sarcoma	0.00132	0.00242	CcSEcCtD
Ranolazine—Constipation—Mitoxantrone—sarcoma	0.00132	0.00242	CcSEcCtD
Ranolazine—Gastrointestinal pain—Vincristine—sarcoma	0.0013	0.00237	CcSEcCtD
Ranolazine—Confusional state—Etoposide—sarcoma	0.00129	0.00237	CcSEcCtD
Ranolazine—Asthenia—Thiotepa—sarcoma	0.00128	0.00235	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—sarcoma	0.00127	0.00233	CcSEcCtD
Ranolazine—Feeling abnormal—Mitoxantrone—sarcoma	0.00127	0.00233	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—sarcoma	0.00127	0.00232	CcSEcCtD
Ranolazine—Pruritus—Thiotepa—sarcoma	0.00126	0.00232	CcSEcCtD
Ranolazine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00126	0.00231	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—sarcoma	0.00126	0.00231	CcSEcCtD
Ranolazine—Thrombocytopenia—Etoposide—sarcoma	0.00126	0.0023	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—sarcoma	0.00125	0.00229	CcSEcCtD
Ranolazine—Abdominal pain—Vincristine—sarcoma	0.00125	0.00229	CcSEcCtD
Ranolazine—Skin disorder—Etoposide—sarcoma	0.00125	0.00228	CcSEcCtD
Ranolazine—Hyperhidrosis—Etoposide—sarcoma	0.00124	0.00227	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—sarcoma	0.00124	0.00227	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00124	0.00227	CcSEcCtD
Ranolazine—Urticaria—Mitoxantrone—sarcoma	0.00123	0.00225	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—sarcoma	0.00122	0.00224	CcSEcCtD
Ranolazine—Anorexia—Etoposide—sarcoma	0.00122	0.00224	CcSEcCtD
Ranolazine—Abdominal pain—Mitoxantrone—sarcoma	0.00122	0.00223	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—sarcoma	0.0012	0.0022	CcSEcCtD
Ranolazine—Hypotension—Etoposide—sarcoma	0.0012	0.0022	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—sarcoma	0.00118	0.00217	CcSEcCtD
Ranolazine—Dizziness—Thiotepa—sarcoma	0.00118	0.00216	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—sarcoma	0.00116	0.00212	CcSEcCtD
Ranolazine—Paraesthesia—Etoposide—sarcoma	0.00115	0.00211	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—sarcoma	0.00115	0.0021	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—sarcoma	0.00115	0.0021	CcSEcCtD
Ranolazine—Dyspnoea—Etoposide—sarcoma	0.00114	0.0021	CcSEcCtD
Ranolazine—Somnolence—Etoposide—sarcoma	0.00114	0.00209	CcSEcCtD
Ranolazine—Asthenia—Vincristine—sarcoma	0.00114	0.00208	CcSEcCtD
Ranolazine—Vomiting—Thiotepa—sarcoma	0.00114	0.00208	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—sarcoma	0.00113	0.00207	CcSEcCtD
Ranolazine—Rash—Thiotepa—sarcoma	0.00113	0.00206	CcSEcCtD
Ranolazine—Dermatitis—Thiotepa—sarcoma	0.00113	0.00206	CcSEcCtD
Ranolazine—Headache—Thiotepa—sarcoma	0.00112	0.00205	CcSEcCtD
Ranolazine—Rash—Dactinomycin—sarcoma	0.00112	0.00205	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—sarcoma	0.00112	0.00204	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—sarcoma	0.00111	0.00204	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—sarcoma	0.00111	0.00203	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—sarcoma	0.00111	0.00203	CcSEcCtD
Ranolazine—Asthenia—Mitoxantrone—sarcoma	0.00111	0.00203	CcSEcCtD
Ranolazine—Fatigue—Etoposide—sarcoma	0.00111	0.00203	CcSEcCtD
Ranolazine—Constipation—Etoposide—sarcoma	0.0011	0.00201	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—sarcoma	0.0011	0.00201	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—sarcoma	0.00108	0.00197	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—sarcoma	0.00106	0.00195	CcSEcCtD
Ranolazine—Nausea—Thiotepa—sarcoma	0.00106	0.00194	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—sarcoma	0.00106	0.00194	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—sarcoma	0.00106	0.00194	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—sarcoma	0.00105	0.00193	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—sarcoma	0.00105	0.00192	CcSEcCtD
Ranolazine—Dizziness—Vincristine—sarcoma	0.00105	0.00192	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—sarcoma	0.00103	0.00189	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—sarcoma	0.00103	0.00188	CcSEcCtD
Ranolazine—Urticaria—Etoposide—sarcoma	0.00102	0.00187	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—sarcoma	0.00102	0.00186	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—sarcoma	0.00101	0.00185	CcSEcCtD
Ranolazine—Vomiting—Vincristine—sarcoma	0.00101	0.00185	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—sarcoma	0.001	0.00183	CcSEcCtD
Ranolazine—Rash—Vincristine—sarcoma	0.000999	0.00183	CcSEcCtD
Ranolazine—Dermatitis—Vincristine—sarcoma	0.000998	0.00183	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—sarcoma	0.000998	0.00183	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—sarcoma	0.000996	0.00182	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—sarcoma	0.000996	0.00182	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—sarcoma	0.000993	0.00182	CcSEcCtD
Ranolazine—Headache—Vincristine—sarcoma	0.000993	0.00182	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—sarcoma	0.000985	0.0018	CcSEcCtD
Ranolazine—Vomiting—Mitoxantrone—sarcoma	0.000981	0.0018	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—sarcoma	0.000976	0.00179	CcSEcCtD
Ranolazine—Rash—Mitoxantrone—sarcoma	0.000973	0.00178	CcSEcCtD
Ranolazine—Dermatitis—Mitoxantrone—sarcoma	0.000972	0.00178	CcSEcCtD
Ranolazine—Headache—Mitoxantrone—sarcoma	0.000967	0.00177	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—sarcoma	0.000954	0.00175	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—sarcoma	0.000947	0.00173	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—sarcoma	0.000945	0.00173	CcSEcCtD
Ranolazine—Nausea—Vincristine—sarcoma	0.000941	0.00172	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—sarcoma	0.00094	0.00172	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—sarcoma	0.000933	0.00171	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—sarcoma	0.000926	0.0017	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—sarcoma	0.000923	0.00169	CcSEcCtD
Ranolazine—Asthenia—Etoposide—sarcoma	0.000921	0.00169	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—sarcoma	0.000921	0.00169	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—sarcoma	0.000919	0.00168	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—sarcoma	0.000919	0.00168	CcSEcCtD
Ranolazine—Nausea—Mitoxantrone—sarcoma	0.000917	0.00168	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—sarcoma	0.000913	0.00167	CcSEcCtD
Ranolazine—Pruritus—Etoposide—sarcoma	0.000908	0.00166	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—sarcoma	0.000905	0.00166	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—sarcoma	0.000903	0.00165	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—sarcoma	0.000888	0.00163	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—sarcoma	0.000882	0.00161	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—sarcoma	0.000876	0.0016	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—sarcoma	0.000874	0.0016	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—sarcoma	0.00087	0.00159	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—sarcoma	0.000869	0.00159	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—sarcoma	0.00085	0.00156	CcSEcCtD
Ranolazine—Dizziness—Etoposide—sarcoma	0.000849	0.00155	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—sarcoma	0.000848	0.00155	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—sarcoma	0.000845	0.00155	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—sarcoma	0.000837	0.00153	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—sarcoma	0.000831	0.00152	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—sarcoma	0.000821	0.0015	CcSEcCtD
Ranolazine—Vomiting—Etoposide—sarcoma	0.000816	0.0015	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—sarcoma	0.000816	0.00149	CcSEcCtD
Ranolazine—Rash—Etoposide—sarcoma	0.00081	0.00148	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—sarcoma	0.000809	0.00148	CcSEcCtD
Ranolazine—Headache—Etoposide—sarcoma	0.000804	0.00147	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—sarcoma	0.000804	0.00147	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—sarcoma	0.000792	0.00145	CcSEcCtD
Ranolazine—Syncope—Epirubicin—sarcoma	0.000791	0.00145	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—sarcoma	0.000789	0.00145	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—sarcoma	0.000785	0.00144	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—sarcoma	0.000779	0.00143	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—sarcoma	0.000775	0.00142	CcSEcCtD
Ranolazine—Cough—Epirubicin—sarcoma	0.00077	0.00141	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—sarcoma	0.000769	0.00141	CcSEcCtD
Ranolazine—Nausea—Etoposide—sarcoma	0.000763	0.0014	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—sarcoma	0.000748	0.00137	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000746	0.00137	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—sarcoma	0.000734	0.00134	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—sarcoma	0.000733	0.00134	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—sarcoma	0.000732	0.00134	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—sarcoma	0.00073	0.00134	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—sarcoma	0.000726	0.00133	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—sarcoma	0.000721	0.00132	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—sarcoma	0.000717	0.00131	CcSEcCtD
Ranolazine—Cough—Doxorubicin—sarcoma	0.000712	0.0013	CcSEcCtD
Ranolazine—Shock—Epirubicin—sarcoma	0.000708	0.0013	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—sarcoma	0.000706	0.00129	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—sarcoma	0.000705	0.00129	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—sarcoma	0.000699	0.00128	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—sarcoma	0.000696	0.00127	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—sarcoma	0.000692	0.00127	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00069	0.00126	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—sarcoma	0.000686	0.00126	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—sarcoma	0.000679	0.00124	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—sarcoma	0.000673	0.00123	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—sarcoma	0.000671	0.00123	CcSEcCtD
Ranolazine—Shock—Doxorubicin—sarcoma	0.000655	0.0012	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—sarcoma	0.000653	0.0012	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—sarcoma	0.000652	0.00119	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—sarcoma	0.000651	0.00119	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—sarcoma	0.000647	0.00118	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—sarcoma	0.000646	0.00118	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—sarcoma	0.000644	0.00118	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—sarcoma	0.000642	0.00118	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—sarcoma	0.00064	0.00117	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—sarcoma	0.000635	0.00116	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—sarcoma	0.000634	0.00116	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—sarcoma	0.000626	0.00115	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—sarcoma	0.000622	0.00114	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000621	0.00114	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—sarcoma	0.000621	0.00114	CcSEcCtD
Ranolazine—Constipation—Epirubicin—sarcoma	0.000615	0.00113	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—sarcoma	0.000602	0.0011	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—sarcoma	0.000598	0.0011	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—sarcoma	0.000594	0.00109	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—sarcoma	0.000593	0.00109	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—sarcoma	0.000592	0.00108	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—sarcoma	0.000589	0.00108	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—sarcoma	0.000586	0.00107	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—sarcoma	0.000579	0.00106	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000575	0.00105	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—sarcoma	0.000574	0.00105	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—sarcoma	0.000572	0.00105	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—sarcoma	0.000569	0.00104	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—sarcoma	0.000569	0.00104	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—sarcoma	0.000549	0.001	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000545	0.000997	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—sarcoma	0.000529	0.000969	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—sarcoma	0.000526	0.000964	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—sarcoma	0.000516	0.000946	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—sarcoma	0.000509	0.000933	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—sarcoma	0.000478	0.000875	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—sarcoma	0.000476	0.000872	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—sarcoma	0.000471	0.000863	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—sarcoma	0.000458	0.000838	CcSEcCtD
Ranolazine—Rash—Epirubicin—sarcoma	0.000454	0.000831	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—sarcoma	0.000453	0.00083	CcSEcCtD
Ranolazine—Headache—Epirubicin—sarcoma	0.000451	0.000826	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—sarcoma	0.00044	0.000806	CcSEcCtD
Ranolazine—Nausea—Epirubicin—sarcoma	0.000428	0.000783	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—sarcoma	0.000423	0.000775	CcSEcCtD
Ranolazine—Rash—Doxorubicin—sarcoma	0.00042	0.000769	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—sarcoma	0.00042	0.000768	CcSEcCtD
Ranolazine—Headache—Doxorubicin—sarcoma	0.000417	0.000764	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—sarcoma	0.000396	0.000724	CcSEcCtD
